AIM Centre
Merewether, New South Wales, Australia
Specialized clinic in New South Wales
41 Llewellyn St, Merewether NSW 2291
About AIM Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Eli Lilly and Company
2
GeNeuro Australia PTY Ltd
1
Zafgen, Inc.
1
Clinical Trials at AIM Centre
During the past decade, AIM Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730
Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years
2017-06-14
2019-05-07
Completed
64
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
2017-09-12
2019-02-22
Completed
188
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
2019-02-14
2020-01-06
Completed
471
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AIM Centre"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Southern Star Research Pty Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at AIM Centre
According to Clinical.Site data, the most researched conditions in "AIM Centre" are
"Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus Type 1" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Overweight and Obesity" (1 trials). Many other conditions were trialed in "AIM Centre" in a lesser frequency.
Clinical Trials Intervention Types at AIM Centre
Most popular intervention types in "AIM Centre" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (1 trials), "GNbAC1" (1 trials), "Insulin Glargine" (1 trials) and "Insulin Lispro" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AIM Centre
The vast majority of trials in "AIM Centre" are
6 trials for "All" genders.
Clinical Trials Status at AIM Centre
Currently, there are NaN active trials in "AIM Centre".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in AIM Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AIM Centre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".